Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 2c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.95), $0.02 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• ASM International NV (ASM:NA) PT Raised to EUR1,174 at JPMorgan
• Happy Belly Food Group raises $8.35M through warrant exercises